Discovery and development of the anticancer agent salinosporamide A (NPI-0052)

This publication has 45 references indexed in Scilit:

• Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells
  Clinical Cancer Research, 2008
• Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma
  Blood, 2008
• Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB–regulated gene products
  Blood, 2007
• NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
  Blood, 2007
• Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica
  Proceedings of the National Academy of Sciences, 2007
• Concise Total Synthesis of (±)-Salinosporamide A, (±)-Cinnabaramide A, and Derivatives via a Bis-cyclization Process: Implications for a Biosynthetic Pathway?
  Organic Letters, 2007
• Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae
  International Journal of Systematic and Evolutionary Microbiology, 2005
• Bioactive Microbial Metabolites
  The Journal of Antibiotics, 2005
• Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora
  Angewandte Chemie International Edition in English, 2003
• Structure of 20S proteasome from yeast at 2.4Å resolution
  Nature, 1997